Polaris Oncology Survivor Transition (POST) System

计划入组 200 人 · 首次发布于 2015 年 12 月 22 日

Prospective, Post Market Surveillance Q3-registry (POLARIS)

计划入组 250 人 · 首次发布于 2014 年 12 月 4 日

Melodi Matrix™ in Breast Reconstruction

计划入组 702 人 · 首次发布于 2023 年 9 月 7 日

Polaris

ENKASTIM™

Covax-19™

JAPAN BREAST CANCER RESEARCH GROUP

Japan

International Breast Cancer Research Foundation

United States

Spanish Breast Cancer Research Group

Spain

StratifAI Partners with Memorial Sloan Kettering to Validate AI-Powered Breast Cancer Biomarker Platform

AriBio's AR1001 Phase 3 Trial for Early Alzheimer's Enrolls First Patients

Tensive Reports Positive Pivotal Trial Results for REGENERA™ Bioresorbable Breast Reconstruction Device